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Abstract
Caveolae, little caves of cell surfaces, are enriched in cholesterol, a certain level of which is required for their structural
integrity. Here we show in adipocytes that cavin-2, a peripheral membrane protein and one of 3 cavin isoforms present in
caveolae from non-muscle tissue, is degraded upon cholesterol depletion in a rapid fashion resulting in collapse of caveolae.
We exposed 3T3-L1 adipocytes to the cholesterol depleting agent methyl-b-cyclodextrin, which results in a sudden and
extensive degradation of cavin-2 by the proteasome and a concomitant movement of cavin-1 from the plasma membrane
to the cytosol along with loss of caveolae. The recovery of cavin-2 at the plasma membrane is cholesterol-dependent and is
required for the return of cavin-1 from the cytosol to the cell surface and caveolae restoration. Expression of shRNA directed
against cavin-2 also results in a cytosolic distribution of cavin-1 and loss of caveolae. Taken together, these data
demonstrate that cavin-2 functions as a cholesterol responsive component of caveolae that is required for cavin-1
localization to the plasma membrane, and caveolae structural integrity.
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Introduction
Small (60–80 nm) invaginations of the cell surface called
caveolae are common features of many cell types, which possess
diverse physiological roles, for example, endothelial and epithelial
cells, cardiac and skeletal muscle [1,2], and of particular relevance
herein, adipocytes [3,4]. In line with this physiological diversity,
caveolae have been found to play a role in numerous biological
processes including signal transduction, endocytosis, mechano-
transduction, cellular viral entry and regulation of fuel metabolism
[1,2,3,4]. Considering the pleiotropic nature of their possible
physiological and functional roles, there has been no grand unified
theory for the biochemical/mechanistic properties of caveolae,
and most efforts to understand mechanism(s) have focused on the
critical protein constituents of caveolae, the caveolins and cavins.
The caveolins consist of three isoforms (Cav1-3) of small (151–178
amino acids) integral membrane proteins positioned entirely on
the cytoplasmic face of the plasma membrane, Cav1 and -2 being
expressed together in non-muscle tissue and Cav-3 being muscle
specific [5]. There are four cavin isoforms ranging in size from 260
to 418 residues (murine) with the properties of peripheral
membrane proteins, and they have leucine zipper (cavin-1-3)
and PEST (proline, aspartate, serine, threonine) domains (all).
Cavin-1 and cavin-2 are critical for caveola formation, whereas
cavin-3 and cavin-4, the last being muscle-specific, may be
dispensable in this regard [1,2,6]. The caveolins have been
postulated to have a number of specific biochemical actions, but
little is known in this regard concerning the cavins.
The physiological importance of caveolae has been underscored
by the phenotypes of organisms lacking these structures as a result
of natural mutations of caveolins and cavin-1 in humans and gene
knockouts in mice. Loss of murine Cav1 causes vascular defects
and insulin resistance [7,8,9,10] and similar pathologies are seen in
humans harboring Cav1 null alleles [11,12]. Mice lacking Cav-3
have metabolic defects as well as muscular dystrophy [13,14] as do
humans with inactivating mutations in this protein [15]. Cavin-1
knockout mice exhibit insulin resistance and metabolic defects
[16], a phenotype similar or identical to that of humans lacking
this protein, who also have muscle and cardiac abnormalities
[17,18,19,20].
The insulin resistance metabolic phenotype of Cav1 and cavin-1
deficient mammals derives, at least in part, from defects in lipid
storage in adipocytes, and includes diminished insulin action and
abnormal lipolysis [4,21,22]. Although a complete molecular
picture describing the properties of the caveola deficient fat cell is
still lacking, an inability to store fat normally by whatever
mechanism is associated with additional metabolic dysfunctions in
other peripheral tissues, namely liver and muscle [23]. Because
caveolae comprise as much as 50% of the plasma membrane area
in primary fat cells [24], probably the highest level of any cell type,
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function. Moreover, the large lipid droplets, the triglyceride
storage organelle of the fat cell [25] also serve as the largest
reservoir of free cholesterol in the body [26], although the
dynamics of this pool have not heretofore been investigated.
An early-recognized feature of caveolae is their dependence on
cholesterol, loss of which causes these structures to lose their
characteristic shape [27,28]. Indeed, Cav1 was shown to bind
cholesterol in a stoichiometric fashion [29]. These prior studies of
the cholesterol-dependency of caveolae focused largely on the
behavior of Cav1, the only protein known to be required for
caveolae structure in non-muscle cells until the recent studies of
the cavins, which documented their role in caveolae formation
[16,30,31,32]. We revisited the cholesterol depletion experimental
paradigm in adipocytes in light of the possible role(s) of the cavin
proteins in order to gain possible insight into cholesterol dynamics
and the hierarchy and relationships amongst caveolae protein
constituents in caveolae biology/biochemistry. Remarkably, we
find that cavin-2 behaves in a switch-like fashion with regard to
plasma membrane (PM) cholesterol content, and it is required for
caveolae integrity and cavin-1 localization to the PM in
adipocytes.
Materials and Methods
Antibodies
Polyclonal antibody directed against Cav1 was obtained from
BD Transduction Laboratories (San Jose, CA, USA). Anti-actin
and anti-GAPDH were purchased from Sigma (St. Louis, MO.,
USA). Polyclonal rabbit antibodies recognizing cavin-1, cavin-2,
and cavin-3 were generated by 21st Century Biochemicals
(Marlboro, MA, USA) using synthetic peptides as described [6].
Anti-rabbit Cy3 conjugated secondary antibody was from
Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA,
USA).
Reagents
TransIt-293 transfection reagent was purchased from Mirus
(Madison, WI, USA). Simvastatin was purchased from Cayman
Chemical (Ann Arbor, MI, USA). Methyl-b-cyclodextrin, filipin
III, nystatin, cholesterol-loaded cyclodextrin, and chloroquine
were purchased from Sigma (St. Louis, MO, USA) as were
dexamethasone (DEX), 3-isobutyl-1-methylxanthine (MIX), Tet-
ramethyl Rhodamine Isothiocyanate (TRITC)-Phalloidin and
insulin. Lipoprotein-deficient fetal bovine serum (FBS) was
purchased from Kalen Biomedical (Montgomery Village, MD,
USA). MG-132 was purchased Calbiochem (Gibbstown, NJ,
USA). Aprotinin, pepstatin and leupeptin were from American
Bioanalytical, Natick, MA, USA.
Cell culture
Primary mouse embryonic fibroblasts (MEFs) from wild type
mice and MEFs from caveolin-1 null mice were kindly provided
by Dr. Robert Parton, University of Queensland, Australia [33].
3T3-L1 Fibroblasts (from ATCC) were maintained in DMEM
containing 4.5 g/liter glucose and l-glutamine from Mediatech
Inc., (Herndon, VA, USA) supplemented with 10% calf serum
and 100 units/ml penicillin, and 100 mg/ml streptomycin
(Invitrogen). 48 hours post-confluence, 3T3-L1 fibroblasts were
induced to differentiate by changing the media to DMEM
supplemented with 10% fetal bovine serum, 0.5 mm 3-isobutyl-
methylxanthine, 1 mM dexamethasone, and 1.7 mM insulin [34].
48 hours post induction, the induction medium was removed and
cells were maintained in DMEM with 10% fetal bovine serum.
NIH-3T3 (from ATCC) and MEFs were maintained in DMEM
with 10% fetal bovine serum in 5% CO2. Induction of
differentiation for caveolin-1 null MEFs was identical to the
protocol for 3T3-L1 cells except that Troglitazone (5 mM) (gift
from Pfizer, Groton, CT, USA) was added through induction and
differentiation.
Lentiviral infection
HEK-293T (from Open Biosystems) cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) containing 10%
Fetal Bovine serum (Invitrogen), to 90% confluence in p100
dishes, at which stage they were dissociated with trypsin and plated
into p150 dishes. After re-plating for 24 hours, the cells were
transfected with 24 mg of backbone expressing shRNA against
either eGFP or cavin-2, 1.2 mg of TAT, 1.2 mg of REV, 1.2 mg
Gag/Pol, and 2.4 mg of Vsv-G. Two days post-transfection,
medium was collected from the cells, and passed through a
0.45 mM filter with 8 mg/mL (final) polybrene onto target cells.
Two days post infection, cells were selected with 2.5 mg/mL
puromycin. Following selection, cells were screened for the
efficiency of knockdown. The lentiviral vectors expressing shRNA
against cavin-2 were purchased as a set from Open Biosystems
(Hunstville, AL, USA).
Preparation of Whole Cell Extracts
Cells were washed twice with PBS and incubated for 30 minutes
on ice with cold RIPA buffer (50 mM Tris, pH 7.4; 150 mM
NaCl; 1% Nonidet, 0.5% sodium deoxycholate and 0.1%SDS)
with a protease inhibitor cocktail (aprotinin 10 mg/ml, pepstatin
1 mg/ml and leupeptin 1 mg/ml), or for some experiments, the
same ingredients with SDS at 1%. Lysates were placed on an end-
over-end rocker for 30 minutes at 4C and spun down for 10 min
at 16,0006g at 4C. Protein concentrations were determined in the
supernatant using BCA reagent (Pierce, Rockford, IL, USA).
Cell Fractionation
Cells were incubated with or without the indicated treatment as
labeled, and then washed twice with cold PBS, and one time with
cold HES buffer prior to homogenization with a Teflon-glass tissue
homogenizer in HES buffer. Homogenates were spun at 10006g
to remove nuclei and debris. Homogenates were then spun at
231,0006 g to generate a pellet containing membrane fractions
and a supernatant containing cytosol. Buffers used with fraction-
ation contained a mix of protease inhibitors, which contained
1 mM aprotinin, 10 mM leupeptin, 1 mM pepstatin.
Cholesterol determination
The assay was performed as outlined previously [35]. Briefly,
the total amount of cellular cholesterol was determined by
extracting lipids [36] from whole cell extracts and membrane
preparations, and the lipid phase was assayed by a colorimetric
procedure (horseradish peroxidase) to detect cholesterol.
Gel Electrophoresis and Immunoblotting
Proteins were resolved by SDS-PAGE and electrophoretically
transferred to PVDF membrane (Bio-Rad, Hercules, CA, USA).
The membrane was blocked with 10% nonfat dry milk in PBS
containing 0.5% Tween-20 for 1 hour at room temperature.
Primary antibodies were detected using secondary antibodies
conjugated to horseradish peroxidase (Sigma) and enhanced-
chemiluminescence substrate from PerkinElmer Life Sciences
(Boston, MA, USA). Quantitative analysis of Western blots was
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scanner used for the blots.
Confocal Laser Scanning Microscopy
Cells were grown in p100 dishes and induced to differentiate as
described. On day 6 of differentiation cells were trypsinized, and
plated into 6 well plates containing coverslips coated with 0.1%
gelatin (Millipore, Billerica, MA,USA) On day 8 experiments
were conducted and cells were fixed with 4% paraformaldehyde in
PBS for 15 min at room temperature. Cells were permeabilized
with solution A (0.1% saponin (Sigma) and 0.4% BSA in PBS) for
10 min and then blocked for 1 hour at room temperature in 5%
normal goat serum (Sigma) in PBS. Staining was performed with
indicated antibodies overnight at 4uC at a dilution of 1/100 in 1%
normal goat serum in PBS. Following staining cells were washed
four times with buffer A. Cells were incubated anti-rabbit Cy3-
conjugated secondary antibody at a dilution of 1/250 in 1%
normal goat serum in PBS for 1 hour at room temperature. The
cells were washed again for 3 times with solution A and then
mounted with Vectashield mounting medium with DAPI (Vector
Laboratories, Inc. Burlingame, CA, USA). The stained cells were
observed using a Zeiss 510 confocal laser-scanning microscope
(Carl Zeiss, Thornwood, NY, USA). Images were processed using
LSM 510 Image software. Microscopy data shown (confocal and
EM) are representative of 3 or more experiments as are all
Western blot experiments.
Electron Microscopy
Freeze drying of 3T3-L1 membrane lawns was performed as
described [37,38]. Briefly, plasma membranes lawns were fixed
with glutaraldehyde, and after washing with water and methanol
as cryoprotectant, they were rapidly frozen against a copper block
cooled by liquid nitrogen. Plasma membranes were then freeze-
dried in a freeze-etching unit, and rotatory replicas of platinum-
carbon were obtained following the Heuser and Anderson
technique [39].
Results
Methyl-b-cyclodextrin (MbCD) exposure in adipocytes
causes loss of caveolae, cavin-2 degradation and
redistribution of cavin-1 to the cytosol
Cholesterol depletion/sequestration has been shown to disrupt
caveolar structure [27,28,40], which we show for cultured murine
adipocytes in Figure 1A by freeze drying electron microscopy
(EM) of plasma membrane ‘‘lawns’’ [37] following cellular
treatment with 20 mM MbCD. Moreover, as shown by Western
blotting of cell lysates from fat cells exposed to MbCD for the
times indicated (Figure 1B), there was no significant change in
Cav1 or cavin-1 protein expression during the 90 minute time
course, but strikingly, cavin-2 levels were reduced by 90% in the
interval between 70 and 80 minutes of MbCD exposure. We
measured total and plasma membrane (PM) cholesterol as a
function of time of MbCD exposure and the former is unchanged
(Figure 1C), but the latter (Figure 1D) shows that the loss of
cavin-2 occurs upon a change in PM cholesterol from 0.53% to
0.48% of the control value. Thus, cavin-2 is highly sensitive to
small changes over a narrow window of PM cholesterol levels
(Fig. 1D).
In order to understand the fate of the caveolar components
upon cholesterol depletion, in Figure 2 we followed their
distribution by immunofluorescence, and by SDS-PAGE after cell
fractionation and exposure to inhibitors of protein degradation. As
shown in Figure 2A by immunofluorescence and in 2B by cell
fractionation, Cav1 and the cavins all exhibit primarily (cavin-1,
8163%) plasma membrane (cell rim) staining in the control
condition, but cavin-1 redistributes to the cytosol (8366%,
100,0006 g supernatant, see also reference 31) upon cholesterol
depletion and loss of cavin-2, whereas Cav1 and cavin-3 remain
associated with the PM under these conditions. The loss of cavin-2
is a result of its proteosomal degradation as is shown in Figure 2C
by Western blot. The proteosomal inhibitor, MG-132, prevents
loss of cavin-2, whereas the lysosomal inhibitor chloroquine (CQ)
is without effect, and neither inhibitor has any effect in the absence
of MbCD. We cannot rule out, however, that the punctate cavin-1
staining seen in Figure 2 (and in Figures 3 & 4), is due to its
association with intracellular membranes, from which it dissociates
upon centrifugation (Figure 2B).
Cavin-2 re-expression and membrane targeting occurs
upon cholesterol repletion
The recovery of cavin-2 protein expression after cholesterol
depletion is dependent on cholesterol delivered by either serum
lipoproteins (Figure 3A, left lanes) or by its direct addition in
serum free medium (3A, right most lanes), and does not occur
in the absence of a cholesterol source (3A, middle lanes) over
the time frame of 12–18 hours required for caveolar recovery.
The prolonged recovery is observed despite the presence of a
large free cholesterol pool in the adipocyte lipid droplet [41].
Cavin-1 is re-localized to the PM only upon the re-expression
a n dr e t u r no fc a v i n - 2t ot h eP M( F i g u r e3 B ) .T h et i m ec o u r s eo f
caveolae recovery data in Figure 3A and 3B is essentially
identical to that shown by Hailstones et al. who showed that
restoration of membrane cholesterol also required 18–24 hours
[28].
Cavin-2 silencing redistributes cavin 1 to the cytosol
Expression of shRNA is an independent and highly specific
experimental approach to deplete a target protein, and as shown
in Figure 4A by freeze drying EM, Figure 4B by immunofluores-
cence and Figure 4C by cell fractionation, shRNA directed against
cavin-2 causes .95% loss of this protein and dramatically reduces
caveolae number and alters cavin-1 distribution (Cont., 8966%
membrane-associated, 963% cytosol versus 1165% membrane,
9166% cytosol). The freeze drying EM of the intracellular face of
the PM from cavin-2 deficient adipocytes after shRNA delivery
(Figure 4A, panel B) shows a marked reduction in the number of
caveolae. Some of the caveolae present in the cavin-2 deficient
cells show a torus shape (black arrows) and others appear
completely flat (white arrows) similar to what has been described
upon filipin and nystatin treatments in 3T3-L1 adipocytes,
respectively [37]. Figures 4B and 4C show the redistribution of
cavin-1 from the PM to the cytosol upon loss of cavin-2, but Cav1
and cavin-3 remain at the cell surface under these conditions as
they do with the MbCD protocols (Figure 2A & 2B). Owing to the
48 hr. incubation required for the effects of shRNA to be manifest,
there is a reduction in Cav1 levels under these conditions
(Figure 4C) consistent with previous cavin-2 knockdown studies
[6,32]
Cholesterol depletion by antibiotics and statin cause loss
of cavin-2 in fat cells and fibroblasts
As shown in Figure 5A, reduction in the level of cavin-2 can be
achieved using 3 additional reagents targeting cholesterol
sequestration and synthesis, namely overnight exposure of cells
to simvastatin, an inhibitor of HMGCoA reductase [42,43], hence
cholesterol biosynthesis, and exposure to the cholesterol binding
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depleted cholesterol in 3T3 fibroblasts with the same agents used
in Figure 5A, and as shown in Figure 5B by Western blotting, we
see a significant loss of cavin-2 under these conditions with little or
no change in the levels of the other cavins and Cav1. These results
demonstrate that the cholesterol sensitivity of cavin-2 is not strictly
a property of adipocytes.
Cholesterol depletion in the absence of Cav1 causes
redistribution of cavin 2 to the cytosol
We created a permanent adipocyte cell line from Cav1 null
MEFs and showed that they express all three cavins, albeit cavin-2
and cavin-3 to a lesser extent than in Cav1 positive control cells
[33]. Here we show that cholesterol depletion in the Cav1 null fat
cells also results in loss of cavin-2 (Figure 6A), although to a lesser
degree than observed in wild type fat cells (see Figure 1B), and this
occurs with no reduction cavin-1 and cavin-3 (Figure 6A).
Interestingly in Cav1 null fat cells, cholesterol depletion causes
cavin-2 to redistribute to the cytosol (Figure 6B) and it is degraded
to a lesser extent than in Cav1 positive cells (Figure 6A compared
to Figure 1B).
Discussion
Adipocytes have a unique cyto-architecture by virtue of their
large lipid droplets, the triglyceride storage depots that represent a
cell-specific organelle [25,44], and as noted in the introduction,
they have particularly abundant numbers of caveolae [24]. This
last property and the fact that cultured fat cells closely resemble
primary adipocytes in their biological properties make them a
useful cell type for probing caveolae structure and function. Here
we show that cavin-2 in adipocytes behaves like a cholesterol-
dependent switch necessary for caveolar structure, and the
degradation of cavin-2 by the proteasome following cholesterol
depletion leads to collapse of caveolae. Interestingly, whereas all
three non-muscle cavins have PEST sequences (proline, gluta-
mate, serine, threonine residues) [6,45] potentially rendering them
susceptible to proteolytic degradation [46], only cavin-2 is
degraded under these conditions (Figures 1B, 2C, 5A). Although
Cav1 can be ubiquinated [47] and degraded in lysosomes [47,48],
it, like cavin-1 and -3, is stable under our experimental conditions
even up to 18 hours in lipid depleted serum following cholesterol
extraction (Fig. 3A).
A specific role for cholesterol in the collapse of caveolae is
supported by the fact that four independent reagents that affect
cholesterol levels, namely MbCD, nystatin, filipin and simvastatin
all lead to loss of cavin-2 and redistribution of cavin-1 from the
PM to the cytosol, and these reagents act over time courses that
range from 70 min. to 18 hrs. (Figures 1, 2 and 5). Cholesterol
repletion is required for recovery of cavin-2 expression and return
of cavin-1 to the cell surface (Figure 3). Thus, the large amount of
free cholesterol present in the adipocyte lipid droplet [41], does
Figure 1. Cholesterol depletion collapses caveolae and causes loss of cavin-2 in a switch-like fashion (A). Freeze drying electron
micrograph depicting the inner surface of the adipocyte plasma membrane before (panels A and B) and after (panels C and D) cholesterol depletion
by 20 mM MbCD for 60 min. (left and right panels respectively, scale bar represents 200 nm). (B). 3T3-L1 adipocytes were treated with 20 mM MbCD
for the indicated time points, lysates were prepared in RIPA buffer and analyzed by SDS-PAGE followed by Western blotting as described in Methods.
(C&D ). Cholesterol was determined as described in the Methods section for whole cell extracts and/or membranes (C, 90 min.) or at the times
indicated (D) after MbCD exposure. The amount of cavin-2 was determined using a Fujifilm LAS-4000 Image Analyzer. The experiments of 1A, 1B and
1D are representative of .4 such experiments and C shows the mean 6 S.E. for triplicate cell preparations. The value for cavin-2 at time zero was set
to 1.0 and subsequent time points are expressed as ratios of this.
doi:10.1371/journal.pone.0034516.g001
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caveolae, at least in the overnight time course of recovery
(Figure 3), and this is a unique observation of our study. The
existence of a large free cholesterol pool in fat cells is consistent
with the ability of cholesterol to diffuse or otherwise traffic [49]
from caveolae and other cell surface pools to the lipid droplet,
which may serve as a long-term (.18 hrs.) buffer for total
organismal cholesterol.
Prior studies of cholesterol depletion and repletion in kidney-
derived cells showed that recovery of caveolae occurred over a
very narrow range of membrane cholesterol content, a threshold
effect [28]. Such threshold or switch-like behavior has also been
shown for the cholesterol-dependent regulation of the sterol
regulatory binding protein (SREBP) in the endoplasmic reticu-
lum (ER) by the cholesterol binding protein Scap (SREBP-
cleavage-activating protein), such that regulation of SREBP is
achieved by changes in ER membrane cholesterol from 3–5% of
the total ER cholesterol content [50]. Our current results are
complementary to these prior studies and raise the question as to
what is the biochemical nature of the cholesterol-dependent
‘‘switch’’ for caveola structure, previously assumed to be Cav1
which is known to bind cholesterol [29]. However, cavin-2
moves from the membrane to the cytosol upon cholesterol
depletion in Cav1-null cells (Figure 6) so Cav1 cannot entirely
explain the cholesterol sensitivity of caveolae. Cavin-1 has a so-
called crac (cholesterol recognition amino acid consensus, [51])
domain (R. Epand, personal communication) as does Cav1 [52],
but the presence or absence of this sequence does not necessarily
rule in or out cholesterol binding [51]. A possibility is that cavin-
1 & -2 participate together as the cholesterol sensitive complex,
as cavin-1 does not target to the membrane in the absence of
Figure 2. Cavin-2 is degraded by the proteosome and Cavin-1 redistributes to the cytosol following cholesterol depletion. 3T3-L1
adipocytes were treated with or without MbCD (20 mM, 90 minutes) and subjected to either (A) immunostaining with the indicated antibodies (red)
and for nuclei with DAPI (49,6-diamidino-2-phenylindole, blue) and analyzed by confocal microscopy as described in Methods or (B), subjected to
subcellular separation into membrane and cytosolic fractions. Following centrifugation, an equal proportion of each fraction (ca. 6X more cytosol
protein than membrane) were analyzed by SDS-PAGE and Western blotting. Glyceraldehyde phosphate dehydrogenase (GAPDH) is a loading control
for the cytosolic fraction. (C) Cultured at cells were treated with or without methylb-cyclodextrin in combination with the proteasome inhibitor MG-
132 (10 mM), the lysosomal inhibitor chloroquine (40 mM), or the inhibitors alone for 90 minutes and cell extracts were prepared in lysis buffer and
analyzed by SDS-PAGE and Western blotting for the proteins indicated. Shown are representative experiments.
doi:10.1371/journal.pone.0034516.g002
Figure 3. Cholesterol repletion restores cavin-2 levels, which
allows return of cavin-1 to the plasma membrane. 3T3-L1
adipocytes were treated without or without methyl-b-cyclodextrin
(20 mM, 90 minutes), and the medium was changed to that containing
either 10% FBS, 10% FBS depleted of lipoproteins (LPDS), or, 10% FBS
lipoprotein depleted serum containing cholesterol loaded cyclodextrin
(25 mM cholesterol). Following incubation for the times indicated (time
0 being after MbCD removal), cell lysates were analyzed by SDS-PAGE
and Western blotting (A) or were processed for immunofluorescence
with antibodies for cavin-1 and -2 (B) and for nuclei (DAPI) as in prior
figures. The percent cavin-2 rim staining was determined by scoring
104+/23 cells that were also positive for DAPI staining.
doi:10.1371/journal.pone.0034516.g003
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be at the cell surface for cholesterol sensitivity. Alternatively
there may be an additional, as yet unknown protein(s), involved
in this process.
There have been a limited number of studies addressing the
mechanism of caveolae assembly because the contribution of the
cavins to caveola structure has only recently been described
(reviewed in [1,2]. Transfection of cavin-1 in Cav1 expressing
cells can result in formation of morphological caveolae [6], but
the present results show that cavin-2 is necessary to recruit
endogenous cavin-1 to the cell surface (Figures 2 and 3), as was
Figure 4. ShRNA mediated knockdown of cavin-2 causes
redistribution of cavin-1 to the cytosol. 3T3-L1 adipocytes stably
expressing shRNA directed against enhanced green fluorescent protein
(eGFP) or cavin-2 were processed for freeze drying electron microscopy
(A) or subjected to immunostaining (B) with the indicated antibodies
(red) and DAPI (blue), and analyzed by confocal microscopy and
quantitatively analyzed as in Figure 3 for 102 cells or (C) subcellular
fractionation into membrane and cytosolic fractions as in Figure 2B.
Following fractionation, proteins were analyzed by SDS-PAGE and
Western blotting, with glyceraldehyde phosphate dehydrogenase
(GAPDH) being used as a loading control for the cytosolic fraction. In
Figure 4A, panel B, black arrows point to torus shaped caveolae and
white arrows to flattened caveolae and the scale bar is 200 nm. In 4B,
the amount of cavin-2 in whole cell lysates is shown. These are
representative of 3 such experiments.
doi:10.1371/journal.pone.0034516.g004
Figure 5. Cholesterol depletion by simvistatin and cholesterol-
binding antibiotics causes loss of cavin-2 in fat cells (A) and
fibroblasts (B). Adipocytes or NIH-3T3 fibroblasts were treated with or
without Simvastatin (10 mM, 18 hrs) methyl-b-cyclodextrin (20 mM,
90 minutes), nystatin (76 mM, 4 hours) or filipin (7.6 mM, 4 hours).
Whole cell extracts were then prepared in RIPA buffer and analyzed by
SDS-PAGE and Western blotting as in prior figures.
doi:10.1371/journal.pone.0034516.g005
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showed that that all 3 cavins formed a complex at the adipocyte
cell surface [6], although cavin-3 appears to be less abundant
than the other cavins in this context and may be more involved
in caveolar dynamics than as a structural requirement [53].
Possible cavin-3 functions aside from caveolae are consistent
with the observation that cavin-3 is expressed in brain and liver
where there is very little expression of the other cavins and Cav1
& 2 [6]. Hayer et al. provided evidence that a cavin complex
could form in the cytosol and be recruited to the PM upon the
arrival there of a Cav1 scaffold complex [54]. However, we
observe cavins at the PM in Cav1 null adipocytes (Figure 6) and
there may therefore be additional proteins that are required for
mature caveolae formation, for example, the adaptor protein,
pacsin-2 [55]. In this regard, our present studies target
endogenous proteins in adipocytes where the abundant caveolae
may play multiple biological roles, particularly with regard to
lipid traffic and storage [3,4,22], and the situation my be
different for gain of function experiments in other cell types that
normally have few caveolae. Additional work is needed to
further establish protein (and lipid) hierarchies in caveola
assembly.
The adipocyte is a terminally differentiated specialized cell and
it is of interest to know whether or not the cholesterol sensitivity of
cavin-2 is specific to this cell type. Indeed we show that it is not, as
fibroblasts also show loss of cavin-2 upon exposure to four
cholesterol-perturbing reagents (Figure 5B). In this case however,
there appears to be a somewhat lesser effect than in adipocytes.
We have also exposed Chinese Hamster Ovary (CHO) cells to
statins and they also lose cavin-2 protein. Thus, the cholesterol
requirement for cavin-2 membrane association appears to be a
general phenomenon. In summary, we describe a novel role for
cavin-2 in sensing/responding to membrane cholesterol, probably
in concert with another membrane component. Loss of cavin-2
causes collapse of caveolae and results in relocalization of cavin-1
to the cytosol.
Acknowledgments
We thank Carmen Lo ´pez-Iglesias from the Scientific & Technological
Centers of the University of Barcelona for technical assistance with the
electron microscopy protocols.
Author Contributions
Conceived and designed the experiments: MRB MC FCS AZ PFP.
Performed the experiments: MRB MC FCS AZ. Analyzed the data: MRB
MC FCS AZ PFP. Contributed reagents/materials/analysis tools: MC
FCS AZ PFP. Wrote the paper: MRB PFP.
References
1. Hansen CG, Nichols BJ (2010) Exploring the caves: cavins, caveolins and
caveolae. Trends Cell Biol 20: 177–186.
2. Bastiani M, Parton RG (2010) Caveolae at a glance. J Cell Sci 123: 3831–3836.
3. Pilch PF, Souto RP, Liu L, Jedrychowski MP, Berg EA, et al. (2007) Cellular
spelunking: exploring adipocyte caveolae. J Lipid Res 48: 2103–2111.
4. Pilch PF, Liu L (2011) Fat caves: caveolae, lipid trafficking and lipid
metabolism in adipocytes. Trends in endocrinology and metabolism: TEM
22: 318–324.
5. Cohen AW, Hnasko R, Schubert W, Lisanti MP (2004) Role of caveolae and
caveolins in health and disease. Physiological reviews 84: 1341–1379.
6. Bastiani M, Liu L, Hill MM, Jedrychowski MP, Nixon SJ, et al. (2009) MURC/
Cavin-4 and cavin family members form tissue-specific caveolar complexes.
J Cell Biol 185: 1259–1273.
7. Drab M, Verkade P, Elger M, Kasper M, Lohn M, et al. (2001) Loss of caveolae,
vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.
Science 293: 2449–2452.
8. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, et al. (2001)
Caveolin-1 null mice are viable but show evidence of hyperproliferative and
vascular abnormalities. J Biol Chem 276: 38121–38138.
9. Zhao YY, Liu Y, Stan RV, Fan L, Gu Y, et al. (2002) Defects in caveolin-1 cause
dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc
Natl Acad Sci U S A 99: 11375–11380.
10. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, et al. (2003)
Caveolin-1-deficient mice show insulin resistance and defective insulin receptor
protein expression in adipose tissue. Am J Physiol Cell Physiol 285: C222–235.
11. Cao H, Alston L, Ruschman J, Hegele RA (2008) Heterozygous CAV1
frameshift mutations (MIM 601047) in patients with atypical partial lipodystro-
phy and hypertriglyceridemia. Lipids Health Dis 7: 3.
12. Kim CA, Delepine M, Boutet E, El Mourabit H, Le Lay S, et al. (2008)
Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-
Seip congenital lipodystrophy. The Journal of clinical endocrinology and
metabolism 93: 1129–1134.
13. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, et al. (2001)
Caveolin-3 null mice show a loss of caveolae, changes in the microdomain
distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.
J Biol Chem 276: 21425–21433.
14. Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, et al. (2005) Caveolin-3
knockout mice show increased adiposity and whole body insulin resistance, with
Figure 6. Cav1 null adipocytes lack caveolae but cavin-2 is
membrane associated and redistributes to the cytosol upon
cholesterol depletion. Cav1 null adipocytes were treated with or
without MbCD as in previous figures and lysates (A) were prepared and
analyzed by Western blot or (B) labeled with anti-cavin-2 and secondary
antibody prior to analysis by confocal microscopy.
doi:10.1371/journal.pone.0034516.g006
Cavin-2 Regulates Caveola Structure and Formation
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34516ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell
Physiol 288: C1317–1331.
15. Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP (2004)
Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal
dominant muscle diseases. Neurology 62: 538–543.
16. Liu L, Brown D, McKee M, Lebrasseur NK, Yang D, et al. (2008) Deletion of
Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose
intolerance. Cell metabolism 8: 310–317.
17. Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, et al. (2009) Human
PTRF mutations cause secondary deficiency of caveolins resulting in muscular
dystrophy with generalized lipodystrophy. J Clin Invest 119: 2623–2633.
18. Dwianingsih EK, Takeshima Y, Itoh K, Yamauchi Y, Awano H, et al. (2010) A
Japanese child with asymptomatic elevation of serum creatine kinase shows
PTRF-CAVIN mutation matching with congenital generalized lipodystrophy
type 4. Mol Genet Metab 101: 233–237.
19. Rajab A, Straub V, McCann LJ, Seelow D, Varon R, et al. (2010) Fatal cardiac
arrhythmia and long-QT syndrome in a new form of congenital generalized
lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.
PLoS Genet 6: e1000874.
20. Shastry S, Delgado MR, Dirik E, Turkmen M, Agarwal AK, et al. (2010)
Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy
due to novel PTRF mutations. Am J Med Genet A 152A: 2245–2253.
21. Le Lay S, Blouin CM, Hajduch E, Dugail I (2009) Filling up adipocytes with
lipids. Lessons from caveolin-1 deficiency. Biochim Biophys Acta 1791:
514–518.
22. Pilch PF, Meshulam T, Breen M, Liu L (2011) Caveolae and lipid trafficking in
adipocytes. Current Lipidology 6: 49–58.
23. Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions
linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:
367–377.
24. Thorn H, Stenkula KG, Karlsson M, Ortegren U, Nystrom FH, et al. (2003)
Cell surface orifices of caveolae and localization of caveolin to the necks of
caveolae in adipocytes. Mol Biol Cell 14: 3967–3976.
25. Murphy S, Martin S, Parton RG (2009) Lipid droplet-organelle interactions;
sharing the fats. Biochim Biophys Acta 1791: 441–447.
26. Krause BR, Hartman AD (1984) Adipose tissue and cholesterol metabolism.
J Lipid Res 25: 97–110.
27. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, et al. (1992)
Caveolin, a protein component of caveolae membrane coats. Cell 68: 673–682.
28. Hailstones D, Sleer LS, Parton RG, Stanley KK (1998) Regulation of caveolin
and caveolae by cholesterol in MDCK cells. J Lipid Res 39: 369–379.
29. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, et al. (1995)
VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci U S A 92:
10339–10343.
30. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, et al. (2008)
PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation
and function. Cell 132: 113–124.
31. Liu L, Pilch PF (2008) A critical role of cavin (polymerase I and transcript release
factor) in caveolae formation and organization. J Biol Chem 283: 4314–4322.
32. Hansen CG, Bright NA, Howard G, Nichols BJ (2009) SDPR induces
membrane curvature and functions in the formation of caveolae. Nat Cell Biol
11: 807–814.
33. Meshulam T, Breen MR, Liu L, Parton RG, Pilch PF (2011) Caveolins/
caveolae protect adipocytes from fatty acid-mediated lipotoxicity. Journal of
lipid research 52: 1526–1532.
34. Green H, Kehinde O (1975) An established preadipose cell line and its
differentiation in culture. II. Factors affecting the adipose conversion. Cell 5:
19–27.
35. Meshulam T, Simard JR, Wharton J, Hamilton JA, Pilch PF (2006) Role of
caveolin-1 and cholesterol in transmembrane fatty acid movement. Biochemistry
45: 2882–2893.
36. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation
and purification of total lipides from animal tissues. The Journal of biological
chemistry 226: 497–509.
37. Ros-Baro A, Lopez-Iglesias C, Peiro S, Bellido D, Palacin M, et al. (2001) Lipid
rafts are required for GLUT4 internalization in adipose cells. Proceedings of the
National Academy of Sciences of the United States of America 98:
12050–12055.
38. Gonzalez-Munoz E, Lopez-Iglesias C, Calvo M, Palacin M, Zorzano A, et al.
(2009) Caveolin-1 loss of function accelerates glucose transporter 4 and insulin
receptor degradation in 3T3-L1 adipocytes. Endocrinology 150: 3493–3502.
39. Heuser JE, Anderson RG (1989) Hypertonic media inhibit receptor-mediated
endocytosis by blocking clathrin-coated pit formation. The Journal of cell
biology 108: 389–400.
40. Parpal S, Karlsson M, Thorn H, Stralfors P (2001) Cholesterol depletion
disrupts caveolae and insulin receptor signaling for metabolic control via insulin
receptor substrate-1, but not for mitogen-activated protein kinase control. The
Journal of biological chemistry 276: 9670–9678.
41. Krause BR, Hartman AD (1978) Quantification of adipocyte free and esterified
cholesterol using liquid gel chromatography. Journal of lipid research 19:
774–777.
42. Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature
343: 425–430.
43. Smart EJ, Anderson RG (2002) Alterations in membrane cholesterol that affect
structure and function of caveolae. Methods in enzymology 353: 131–139.
44. Bickel PE, Tansey JT, Welte MA (2009) PAT proteins, an ancient family of lipid
droplet proteins that regulate cellular lipid stores. Biochim Biophys Acta 1791:
419–440.
45. Aboulaich N, Vainonen JP, Stralfors P, Vener AV (2004) Vectorial proteomics
reveal targeting, phosphorylation and specific fragmentation of polymerase I and
transcript release factor (PTRF) at the surface of caveolae in human adipocytes.
The Biochemical journal 383: 237–248.
46. Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by
proteolysis. Trends in biochemical sciences 21: 267–271.
47. Hayer A, Stoeber M, Ritz D, Engel S, Meyer HH, et al. (2010) Caveolin-1 is
ubiquitinated and targeted to intralumenal vesicles in endolysosomes for
degradation. The Journal of cell biology 191: 615–629.
48. Forbes A, Wadehra M, Mareninov S, Morales S, Shimazaki K, et al. (2007) The
tetraspan protein EMP2 regulates expression of caveolin-1. The Journal of
biological chemistry 282: 26542–26551.
49. Le Lay S, Hajduch E, Lindsay MR, Le Liepvre X, Thiele C, et al. (2006)
Cholesterol-induced caveolin targeting to lipid droplets in adipocytes: a role for
caveolar endocytosis. Traffic 7: 549–561.
50. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS (2008) Switch-like
control of SREBP-2 transport triggered by small changes in ER cholesterol: a
delicate balance. Cell metabolism 8: 512–521.
51. Epand RM (2008) Proteins and cholesterol-rich domains. Biochimica et
biophysica acta 1778: 1576–1582.
52. Epand RM, Sayer BG, Epand RF (2005) Caveolin scaffolding region and
cholesterol-rich domains in membranes. Journal of molecular biology 345:
339–350.
53. McMahon KA, Zajicek H, Li WP, Peyton MJ, Minna JD, et al. (2009) SRBC/
cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J
28: 1001–1015.
54. Hayer A, Stoeber M, Bissig C, Helenius A (2010) Biogenesis of caveolae:
stepwise assembly of large caveolin and cavin complexes. Traffic 11: 361–382.
55. Hansen CG, Howard G, Nichols BJ (2011) Pacsin 2 is recruited to caveolae and
functions in caveolar biogenesis. Journal of cell science 124: 2777–2785.
Cavin-2 Regulates Caveola Structure and Formation
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34516